Navigation Links
Gene variant leads to better memory via increased brain activation
Date:10/17/2011

Carriers of the so-called KIBRA T allele have better memories than those who don't have this gene variant. This means we can reject the theory that the brain of a non-bearer compensates for this. This is shown by researchers from Ume University in The Journal of Neuroscience.

In this study, KIBRA was first examined in relation to the memory performance of a group of 2,230 subjects. Just as in previous studies, carriers of the KIBRA T allele performed better than non-carriers. Then the brain activity of 83 subjects was studied with the help of fMRI. In contrast with the earlier study, higher activation of the hippocampus was observed in T carriers than in non-carriers.

Thanks to the large number of subjects in the study, the effect could also be studied in a group in which T carriers performed better (83 individuals) and in a subgroup in which the memory performance was equal between T carriers and non-carriers (63). This is especially important as differences in memory performance are regarded to be of significance in how to interpret differences in brain activation. However, in both cases, T carriers had increased hippocampus activation, which means that the effect of KIBRA on brain activation as such is not dependent on the difference in memory performance but is of importance for memory performance.

The conclusion must be that there is no support for the previous theory regarding compensatory mechanisms in non-carriers of the T allele. Instead the new findings indicate that the KIBRA gene plays a role in memory by improving the hippocampus function in carriers of the T allele.

In a study published in Science in 2006 the entire genome was screened (in a so-called Genome-wide association study) for genetic variations of importance to episodic memory (Papassotiropoulos et al., 2006). Individuals who carried the T allele (CT or TT genotype) in a common C/T polymorphism in the KIBRA gene had better episodic memory than non-carriers of the T allele (CC genotype). In the same study, brain activity was examined during a memory task in 30 subjects with the help of a magnetic camera (fMRI). It was found that non-carriers of the T allele had greater activation of the hippocampus, an area in the brain that is important for episodic memory, than did T carriers.

Since the groups had the same memory performance, the results were explained as indicating that non-carriers needed to compensate for their poorer memory function with increased activation of the hippocampus in order to reach the same level of performance as T carriers. Increased activation in the hippocampus is strongly associated with positive aspects of the memory function, and with other genes related to memory the opposite has been observed: increased hippocampus activation in carriers of a gene variant that is associated with better memory (e.g. Hariri et al., 2003). In those cases a reasonable explanation has been that the gene is important for memory via a favorable effect on the hippocampus function.

Improved memory performance in carriers of the KIBRA T allele has been verified in several subsequent studies (e.g. Bates et. al., 2009, Preuschhof et al., 2010), but since the 2006 Science article, this is the first to study KIBRA in relation to brain activation.


'/>"/>

Contact: Bertil Born
bertil.born@adm.umu.se
46-703-886-058
Swedish Research Council
Source:Eurekalert

Related biology news :

1. NIH-funded study connects gene variant to response to asthma drugs
2. UTHealth, BCM researchers find common gene variant associated with aortic dissection
3. Genetic variant linked to development of liver cancer in hepatitis C virus carriers
4. Gene variant increases fatty liver risk and fibrosis progression
5. Gene variant linked with development of COPD in men
6. GW researchers reveal 18 novel subtype-dependent genetic variants for autism spectrum disorders and identify potential genetic markers for diagnostic screening
7. Genetic variants associated with caffeine intake identified
8. Gene variant influences chronic kidney disease risk
9. Gene variants in autism linked to brain development
10. Genetic variants linked to increased risk of common gynecological disease
11. Genome study identifies genetic variant linked to TB susceptibility in Africans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics (AMA), ... maker of unmanned aircraft systems (UAS), are launching a joint program to promote ... and support educational outreach efforts. , AMA and DJI will collaborate on other ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, 2017 ... on venture growth investments in biotechnology and medical ... Richardson , M.D. to Managing Director. ... He is a board observer at InfaCare Pharmaceutical ... investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence Pharmaceuticals ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced today the ... Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial ... physician suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative ...
Breaking Biology Technology: